SOLARAZE- diclofenac sodium gel संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

solaraze- diclofenac sodium gel

pharmaderm a division of fougera pharmaceuticals inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - solaraze® (diclofenac sodium) gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. solaraze® (diclofenac sodium) gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium. solaraze® (diclofenac sodium) gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.